Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer

Featuring perspectives from Dr Bob Li, including the following topics: •      Evolution of targeted therapy for HER2-altered non-small cell lung cancer (NSCLC) (0:00) •      Incidence and management of HER2 amplifications and mutations in NSCLC (10:45) •      Role of ErbB/HER protein family biology in lung cancer (19:03) •      Current and emerging roles of antibody-drug conjugates in lung cancer (33:43) •      Considerations for clinical trial participation and improving access to care for patients with cancer (55:08) •      Management of trastuzumab deruxtecan-associated interstitial lung disease (1:03:18) •      Future of HER2-targeted therapy in lung cancer and beyond (1:14:39) CME information and select publications  

Om Podcasten

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.